TOPIRAMATE
NDC 31722-182, Topiramate, tablet, from Camber Pharmaceuticals, Inc..
- Product NDC
- 31722-182
- Status
- Listed
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215414
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/31722-182 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOPIRAMATE50 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-182-05 | 31722018205 | 500 TABLET in 1 BOTTLE (31722-182-05) |
| 31722-182-60 | 31722018260 | 60 TABLET in 1 BOTTLE (31722-182-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/cefbc5f4-ef5f-4732-ab96-a69a183f0b6b
Use it
Look up 31722-182 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-182 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-182. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.